An ambience of sadness and loss permeated this year’s Sine Die —the last day of the 90-day, Maryland General Assembly Session—as we processed the loss of Maryland House Speaker Michael Busch, a true health care champion. It is fitting that we made so much progress this year.
State Lawmakers, Cancer Researchers Come Together as CPRIT Faces Uncertain Future
HOUSTON – Oct. 23, 2018 – With an estimated 121,860 Texans receiving a cancer diagnosis this year, it has never been more important to discuss what can be done to prevent suffering and death from cancer.
The inaugural American Cancer Society Cancer Action Network of Texas Research Breakfast will bring together leaders in health care, business and government to examine what is at stake should the Cancer Prevention and Research Institute of Texas [CPRIT] lose funding and eventually sunset.
Voters overwhelmingly approved CPRIT 11 years ago, creating lifesaving screenings and programs that have touched the lives of Texans in every single county. CPRIT’s prevention arm prioritizes individuals who are underinsured or uninsured and who are not eligible for services through other existing programs. These innovative and results-driven programs are also expected to leverage existing resources and seek partnerships to maximize reach into the community.
Media are welcome to join Thursday morning to hear about the promising research updates and economic boosts CPRIT has made possible.
Hon. John Zerwas, Texas House of Representatives
David Arthur, CEO of Salarius Pharmaceuticals
Jeff Fehlis, American Cancer Society South Region executive vice president
Dr. Richard Gorlick, MD Anderson Children’s Cancer Hospital chair of pediatrics
Dr. Rick Ngo, ACS CAN board member
Anne Reardon, ACS CAN volunteer and cancer survivor
Janet Shamlian, former NBC News correspondent
WHAT: 2018 Texas Research Breakfast
5701 Main St. – first floor, Phantom Ballroom
Houston, TX 77005
Thursday, Oct. 25
7– 9 a.m.